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Abstract 
Kidney stones are more common in patients with 
inflammatory bowel disease (IBD) than in the general 
population. The main lithogenetic risk factors were 
evaluated in patients affected by Crohn's disease and ul-
cerative colitis. Our results show the presence of sever-
al factors, besides hyperoxaluria, in patients with IBD 
although their behaviour appears different in Crohn' s 
disease and ulcerative colitis at pre- and post-operative 
stages. Before surgery in patients with Crohn's disease 
we found a decreased citrate (p < 0.001) and magnesi-
um (p < 0.005) excretion together with a low urinary 
volume (p < 0.001) and pH (p < 0.005). After surgery 
patients with Crohn's disease showed a further reduction 
of magnesium and citrate. Patients with ulcerative coli-
tis before surgery showed a reduced citrate excretion (p 
< 0.05) and a more acidic pH (p < 0.05) than healthy 
subjects. Surgical treatment of proctocolectomy with 
ilea! pouch-anal anastomosis seems to increase the risk 
of stone formation; in fact, after surgery we observed a 
relevant decrease of urinary volume (p < 0.001), pH (p 
< 0.0001) and urinary excretion of citrate (p <0.0001) 
as well as magnesium (p < 0.005). Patients with IBD 
seem to be at greater risk of stone formation than pa-
tients with idiopathic calcium lithiasis; in fact, they 
show a lower excretion of citrate (p < 0.001) and mag-
nesium (p < 0.001) together with a low urinary pH (p 
< 0.001) and volume (p < 0.001). Urinary volume re-
duction is probably one of the major risk factors togeth-
er with the decrease of small molecular weight inhibitors 
that is a constant finding in all patients with IBD. 
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Crohn's disease, ulcerative colitis, risk factors. 
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Introduction 
Renal stone formation is a well-recognized com-
plication of inflammatory bowel disease [4, 10, 13, 20, 
23, 24]. In 1968, Gelzayd et al. [13] examined 885 pa-
tients with chronic inflammatory bowel disease (IBD) 
and found a renal stone incidence of 7. 2 % ; 72 % of 
these stones were composed of calcium oxalate. Accord-
ing to the results of Smith [23], and Dobbins and Binder 
[10], the nephrolithiasis incidence in patients with IBD 
is about twice that of the general population. Stones are 
composed mostly of calcium oxalate although uric acid 
stones form far more frequently in these patients. 
Therefore, the ratio between these two types of renal 
stones appears to be 3: 1, a ratio significantly lower than 
that observed in idiopathic calcium stone formers ( 12: 1) 
[9]. According to some authors [20], this complication 
might be linked to surgical treatment more than intesti-
nal disease and/or medical treatment. Renal stone for-
mation incidence in patients submitted to surgical 
treatment ranges from 5% to 15% [14, 16, 20, 22]. 
Examination of urine in patients with IBD reveals 
several abnormalities that, except for oxalate [ 1 1], are 
due to malabsorption of water, alkali and protein. These 
urinary alterations include urinary volume decrease [20, 
23], acidic urinary pH [23, 24], hypomagnesiuria [4, 23, 
24], pyrophosphate reduced excretion [24], hypocitrat-
uria [23] and enteric hyperoxaluria [25]. Enteric hyper-
oxaluria is primarily due to increased intestinal absorp-
tion of dietary oxalate at colon level [7, 8]; other studies 
have suggested that enteric hyperoxaluria might depend 
on high dietary intake of protein or on reduced bacterial 
degradation of oxalate [ l]. Enteric hyperoxaluria was 
considered to be one of the major risk factors promoting 
renal stone formation in patients with IBD submitted to 
ilea! resection and/or ileostomy [13, 20]. 
The aim of this work was to establish in 66 
patients affected by Crohn' s disease or ulcerative colitis 
the following points: 
a) urinary changes in the main risk-factors before 
surgical treatment; 
b) urine chemistry changes caused by surgical 
procedures; 
c) different behaviour of urinary abnormalities in 
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Table 1. Ulcerative colitis: Risk factors urinary excretion. 
Values are expressed as mean ± standard deviation (SD); p values are given for healthy subjects versus 



















514.0 ± 147 
205.0 ± 112# 
87.1 ± 35.1 $ 
693.0 ± 337 
27, l ± 10.4AA 
654,0 ± 297A& 
35.5 ± 14.9 
1.01 ± 0.4$ 
5.84 ± 0.32*& 
UC 
403.0 ± 223 
287.0 ± 182r 
82.6 ± 48£ 
528.0 ± 361 
17,7 ± 6,9A 
386,0 ± 207A 
38.1 ± 20.3 
0.96 ± 0.53 
5.56 ± 0.57* 
IPAA 
468.4 ± 157 
156,7 ± 97,4A 
46.5 ± 17$£ 
780.5 ± 291 
16.6 ± 6f 
231.2 ± 161& 
34.3 ± 13.3 
0.57 ± 0,23$" 
5.19 ± 0.35& 
#0.05 < p < 0.10; *p < 0.05; p < 0.02; p < 0.01; fp < 0.005; $p < 0.001; &p < 0.0001. 
Table 2. Ulcerative colitis: Urinary factors concentration. 
The values are expressed as mean ± SD; p values are given for healthy subjects (HS) versus 
patients with ulcerative colitis before (UC) and after surgery (IPAA), and for UC versus IPAA group. 
HS UC IPAA 





Ca mg/di 16.4 ± 8.91" 22.5 ± 10.81 20.1 ± 12.5 " 
Mg mg/di 7 .1 ± 2.5* 6.0 ± i.5 5.9 ± 2.8* 
PO 4 mg/di 71.4 ± 25 .4A& 42.9 ± 23f& 106.5 ± 55&& Ao 
Oxalate mg/I 14.9 ± 8.6 15.4 ± 6.8 22.2 ± 10.3 
Citrate mg/I 616.0 ± 316$# 360.0 ± 295$ 297.0 ± 283# 
GAGs µMil 31. 3 18 
A 
30.5 " 25A• ± ± 12.5 46.0 ± 
" 0.05 0.10; • 0.02; I 0.01; $p 0.05; 
A 
0.005; &p 0.001; #p < p < p < 'P < < p < < < 0.0001. 
-------- ---------- --- ---- -------- ------ ------ ------ -- - - - --- -- ----- -- --- --------- ------------ --- ------- -- -
patients with IBD and in patients with idiopathic calcium 
lithiasis. 
Material and Methods 
The study included 66 patients affected by ulcera-
tive colitis (N = 38) or Crohn's disease (N = 28). The 
disease activity of Crohn' s disease was assessed by 
Crohn's disease activity index (CDAI), described by 
Best et al. [3]; the disease was considered to be quies-
cent at CDAI < 150, and active at CDAI > 150. The 
activity of ulcerative colitis was assessed by the criteria 
suggested by Truelove and Witts [26]: according to these 
authors the disease was classified into 3 categories: 
mild, moderate and severe. Disease activity of Crohn's 
disease was quiescent in 24 cases (12 unresected and 12 
resected) and active in 4 cases. Six patients with ulcera-
tive colitis had a mild disease, 4 patients had a moderate 
disease. Steatorrhea was not present in any of the cases. 
The indication for surgery in patients with Crohn' s dis-
ease were: recurrent small bowel obstruction (N = 6), 
intestinal fistulas (N = 5) and laparotomy for suspected 
appendicitis (N = 3). All but 5 patients with ulcerative 
colitis had pancolitis and underwent surgical treatment 
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either for continuous active disease unresponsive to med-
ical treatment (N = 18) or acute severe colitis (N = 
10). 
The patients were subdivided into 4 groups ac-
cording to the period in which metabolic study was per-
formed: 
a) Patients with ulcerative colitis (UC) before 
surgery (8 males and 2 females with mean age of 34.4 ± 
11.1 years). 
b) Patients with ulcerative colitis submitted to 
proctocolectomy with ilea! pouch-anal anastomosis 
(IPAA) (20 males and 8 females with mean age of 31.6 
± 10.8 years). 
c) Patients with Crohn's disease (CD) at pre-
operative stage (8 males and 6 females with mean age of 
32.0 ± 5.5 years). 
d) Patients with Crohn's disease submitted to 
ilea! resection and right hemicolectomy with end-to-end 
ileotransversostomy (IRRHC) (6 males and 8 females 
with mean age of 40.3 ± 15 years). 
All the subjects were studied in an ambulatory 
setting on their normal home diet and did not receive 
any oral or parenteral supplementation, or drugs at time 
of the urine analysis. A normal renal function evaluated 
as endogenous creatinine clearance (GFR > 85 ml/min) 
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Figure 1. Relative supersaturation indices for calcium 
oxalate and uric acid in patients with ulcerative colitis 
before (UC) and after surgery (!PAA). The bars indi-
cate standard deviation (SD). 
was present in all cases; proteinuria, urinary tract infec-
tion and renal tubular acidification disorders were 
absent. 
The metabolic evaluation included measurements 
of serum and urinary creatinine, uric acid, calcium, 
magnesium. Additional urinary analytes included oxa-
late, citrate, glycosaminoglycans (GAGs), pH and uri-
nary volume. Each value for urinary analytes excretion 
was based on two consecutive 24-hours collections· the 
patients were carefully instructed as to the proper p/oce-
dure to collect 24-hours urine specimens which were col-
lected in plastic bottles with thymol and concentrated hy-
drochloric acid as preservatives. The same metabolic 
study was performed on 100 patients with idiopathic cal-
cium oxalate nephrolithiasis (66 males and 34 females) 
with a mean age of 40.1 ± 14.2 years. 
Enzymatic methods were employed to determine 
oxalate and citrate [5, 17]; GA Gs assay was performed 
according to the Samuell method [21]. The other uri-
nary analytes were measured with conventional methods 
as already described [6]. The normal values of all pa-
rameters were obtained in 51 healthy subjects (HS) (25 
males and 26 females) with a mean age of 36.1 ± 14.3 
years, previously examined [5]. 
The statistical study was done with Student's t-
test. Relative supersaturation indices for uric acid and 
calcium oxalate were obtained for each patient from 
nomograms [ 18]. 
Results 
In this paper, the data of the urinary stone risk 
factors in patients with IBD, who showed a renal stone 
incidence of 8. 3 % at preoperative stage and of 11. 9 % 
after surgery, are reported. The results obtained in our 
patients are considered separately according to the dif-
ferent types of IBD. 
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Table 1 summarizes the results obtained in pa-
tients with ulcerative colitis before and after surgery. 
Patients of the UC group showed a higher calcium excre-
tion than HS even though this data did not reach statisti-
cal significance (t = 1.89; 0.05 < p < 0.10). After 
surgery urinary calcium excretion decreased significantly 
in the group of patients submitted to proctocolectomy 
with ilea! pouch-anal anastomosis (!PAA) when com-
pared with UC group (t = 2.65; p < 0.01), while it was 
similar to the HS group. Patients with ulcerative colitis 
displayed a significantly lower excretion of urinary oxa-
late both before (t = 2.74; p < 0.01) and after surgery 
(t = 4.42; p < 0.001). 
The results of statistical tests of the data in Table 
2 were as follows: Citrate urinary excretion in patients 
with ulcerative colitis was significantly lower both be-
fore (t = 2.72; p < 0.01) and after surgery (t = 6.02; 
p < 0.0001) than in HS. Urinary pH too resulted more 
acid before surgery than in HS (t = 2.19; p < 0.05) and 
even more so after surgical treatment (t = 7.28; p < 
0.0001). The magnesium urinary excretion of the UC 
group showed a relevant lowering both before (t = 3.52; 
p < 0.005) and after surgery (t = 4.31; p < 0.001) in 
comparison with HS. Patients of the !PAA group 
showed also a significant decrease of urinary volume in 
comparison with HS (t = 4.63; p < 0.001) and UC (t = 
2.60; p < 0.02) subjects. The decrease of urinary vol-
ume observed in the !PAA group induced a significant 
increase of urinary concentration of uric acid (t = 3. 05; 
p < 0.005), oxalate (t = 1.94; 0.05 < p < 0.10), and 
GA Gs (t = 1. 86; 0.05 < p < 0.10) observed in the UC 
group as summarized in Table 2. Moreover the !PAA 
concentration of uric acid (t = 3.4; p < 0.005), calcium 
(t = 1.94; 0.05 < p < 0.10), and GAGs (t = 3.01; p 
< 0.005) was higher than that of HS. Citrate urinary 
concentration showed a progressive loweri·ng in UC (t = 
2.36; p < 0.05) and !PAA (t = 4.45; p < 0.0001) 
when compared with HS. The increase of uric acid, cal-
cium and oxalate concentration associated with a lower-
ing of pH and magnesium and citrate concentration in-
duced a relevant increase of relative supersaturation in-
dices for calcium oxalate (p < 0.05) (Fig. 1) and uric 
acid (p < 0.001) (Fig. 1) from pre- to post-operative 
stage. 
These data suggest a high probability of crystal 
formation; in fact in our study we found crystalluria in 
patients with ulcerative colitis only after surgical treat-
ment. Crystalluria incidence was 30% and it was com-
posed as follows: 93 % calcium oxalate dihydrate 
(CaOxD) (Fig. 2) and 7% uric acid. In these patients 
CaOxD aggregates (Fig. 3) were present in 11.1 % of the 
cases. Oxalate concentration was significantly higher in 
patients with crystals than in those without crystals (t = 
2.88; p < 0.01) and even higher in those with aggre-
gates. 
The results obtained in patients with Crohn' s dis-
ease (and the results of the statistical tests) were as 
follows (summarized in Table 3): urinary magnesium 
excretion resulted lower than in HS both before surgery 
R. Caudarella et al. 
Table 3. Crohn's disease: Risk factors urinary excretion. 
Values are expressed as mean ± SD; p values are given for healthy subjects (HS) versus 
patients with Crohn's disease before (CD) and after surgery (IRRHC), and for CD versus IRRHC group. 
HS CD IRRHC 
Uric Acid mg/24h 514.0 ± 147 440.0 ± 151 374.0 ± 177 
Ca mg/24h 205.0 ± 112 178.0 ± 131 166.0 ± 104 A 26A$ 25.4$ Mg mg/24h 87. l ± 35 .1 54.4 ± 35.2 ± 
P0 4 mg/24h 693.0 ± 337 742.0 ± 179 617.0 ± 268 
Oxalate mg/24h 27.1 ± 10.4 22.3 ± 7.7 27.2 ± 13.5 
Citrate mg/24h 654.0 ± 297** 338.0 ± 233* 215.0 ± 253* 
GAGs µM/24h 35.5 ± 14.9 37.3 ± 14.7 29.6 ± 18.1 
Volume ml/min 1.01 ± 0.4* 0.56 ± 0.15*# 0.86 ± 0.41 # 
pH 5.84 ± 0.32A* 5.48 ± 0.54 5.28 ± 0.3 l * 
$ 0.05 p < 0.10; #p < 0.02; 
A 
p < 0.005; • 0.001. < p < 
Table 4. Crohn's disease. Urinary factors concentration. 
Values are expressed as mean ± SD; p values are given for healthy subjects (HS) versus 
patients with Crohn's disease before (CD) and after (IRRHC) surgery, and for CD versus IRRHC group. 
HS CD IRRHC 
Uric Acid mg/di 45.3 ± 19. 3£* 57.2 ± 21. 6£A 3 l. 1 ± 17 o 2*A 
Ca mg/di 16.4 ± 8.9$ 21.4 ± 15.9$ 14.4 ± 6.3 
Mg mg/di 7.1 ± 2.5# 6.8 ± 2.8# 2.7 ± 1. 7## 
PO4 mg/di 71.4 ± 25.4*$ 92.6 ± 46.2** 55.9 ± 33. 1 $* 
Oxalate mg/I 14.9 ± 8.6&* 29.9 ± 13_3&* 22.2 ± 11.4** 
Citrate mg/I 616.0 ± 316$# 422.0 ± 260$A 174.0 ± 294r 
" GAGs µM/1 31.3 ± 18 49.9 ± 23.8 26.6 ± 19.1 
£ 0.05 0. 10; $p • 0.02; 0.01; 
A 
<0.005; &p 0.001; #p 0.0001. <p< < 0.05; p < p < p < < 
---------------------------------------------------------------------------------------------------------
(t = 3.24; p < 0.005) and after surgery (t = 5.39; p < 
0.001). Patients with Crohn's disease also showed be-
fore (t = 3.67; p < 0.001) and after surgery (t = 5.05; 
p < 0.001) a significant decrease of citrate excretion in 
comparison with HS. Urinary pH too resulted more acid 
than in HS before surgery (t = 3.17; p < 0.005) and 
even more so after surgical treatment (t = 5.84; p < 
0.001). Patients of the CD group showed also a relevant 
decrease in urinary volume in comparison with HS (t = 
2.57; p < 0.02); after surgery patients with Crohn's dis-
ease showed an increase of urinary volume (t = 2.63; p 
< 0.02). 
The contrasting behaviour of urinary volume in 
patients with Crohn 's disease before and after surgical 
treatment caused an opposite modification of urinary 
analyte concentration, except for that of citrate and mag-
nesium (Table 4) that resulted higher in the CD group in 
comparison with both HS and IRRHC groups. On the 
contrary, the CD group citrate concentration (t = 2.07; 
p < 0.05) was significantly lower than in HS, with a 
further relevant lowering after surgery (IRRHC versus 
HS: t = 4.94; p < 0.0001; CD versus IRRHC: t = 
2.85; p < 0.01) (Table 4). Magnesium concentration 
showed a significant decrease only after surgical treat-
374 
ment (p < 0.0001) (Table 4). The study of relative 
supersaturation indices for uric acid and namely for cal-
cium oxalate showed no significant modification before 
and after surgery (Fig. 4) even though a larger disper-
sion of the data was present. 
In patients with Crohn' s disease, crystalluria inci-
dence at preoperative stage was 30. 7 % and decreased 
after surgery to 23. 5 % . Furthermore, before surgery 
only calcium oxalate dihydrate (CaOxD) crystals (Fig. 
2) were present in urine; after surgery CaOxD crystals 
were present in 50% of the patients while the other 50% 
showed uric acid crystals (Fig. 5). At the preoperative 
stage patients with crystals showed a greater calcium 
concentration (t = 3.64; p < 0.005) in comparison with 
patients without crystals. On the contrary no difference 
was found in oxalate and uric acid concentration between 
patients with and without crystalluria. After surgery, 
citrate excretion was reduced in all subjects but princi-
pally in patients with crystalluria which showed a severe 
hypocitraturia (68.2 ± 33.2). Moreover, patients with-
out crystalluria showed a greater urinary volume (t = 
2.54; p < 0.02) and a less acidic urinary pH. 
According to some authors [5], renal stone forma-
tion in patients with IBD is more frequent after surgical 
Renal Stone Formation in Patients with Inflammatory Bowel Disease 
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Figure 2. Calcium oxalate dihydrate single crystal. 
Figure 3. Calcium oxalate dihydrate aggregate. 
Figure 4. Relative supersaturation indices for calcium 
oxalate and uric acid in patients with Crohn's disease 
before (CD) and after surgery (IRRHC). 
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treatment; therefore, a comparative analysis was per-
formed on the urinary excretion of the main lithogenetic 
factors between a group of patients with idiopathic calci-
um oxalate nephrolithiasis (SF), and IRRHC and IPAA 
groups (Table 5). Urinary calcium excretion resulted 
lower both in IRRHC (t = 2.99; p < 0.001) and in 
IPAA (t = 4.46; p < 0.001) than in SF. Urinary mag-
nesium too resulted lower in IRRHC (t = 6.52) as well 
as in IPAA group (t = 7.11; p < 0.0001) when com-
pared with SF. Patients both ofIRRHC (t = 1.88; 0.05 
< p < 0.10) and IPAA groups (t = 7.26; p < 0.001) 
showed a lower excretion of oxalate in comparison with 
SF. SF displayed also a higher excretion of uric acid in 
comparison with IRRHC (t = 3.47; p < 0.005) and 
IPAA group (t = 3.23; p < 0.005). Oxalate urinary ex-
cretion appeared reduced in IRRHC (t = 1.88; 0.05 < 
p < 0.10) and in IPAA (t = 7.26; p < 0.001) subjects. 
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Table 5. Urinary excretion of the main risk factors in stone formers (SF) and 
in patients with IBD after surgery (!PAA, IRRHC). 
Values are expressed as mean ± SD; p values are given for stone-formers (SF) versus patients with 
Crohn' s disease (IRRHC) and ulcerative colitis (IPPA) after surgery, or for IRRHC versus IPAA group. 
SF IPAA IRRHC 
Uric Acid mg/24h 647.5 ± 298££ 468.4 ± 157£ 374.0 ± 177£ 
Ca mg/24h 257.0 ± 107#£ 156.7 ± 97# 166.0 ± 104£ 
Mg mg/24h 83.5 ± 26## 46.5 ± 17# 35.2 ± 24# 
Oxalate mg/24h 33.7 ± 12&# 27.2 ± 13& 16.6 ± 6.7# 
Citrate mg/24h 468.0 ± 204## 215.0 ± 253# 231.2 ± 161# 
GAGs µM/24h 30.5 ± 7.4 34.3 ± 13 29.6 ± 18 
Volume ml/min 1.52 ± 0.49$# 0.57 ± 0.23$ 0.86 ± 0.41# 
pH 5.79 ± 0.69#* 5.19 ± 0_35# 5.28 ± 0.31 * 
& 0.05 <p< 0.10; p < 0.025; • p < 0.01; £p < 0.005; #p < 0.001; $p < 0.0001 
6 p < 0.005 
30 r-P < 0.01 
25 
.c ..,. 
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Figure 6. Oxalate urinary excretion in healthy subjects 
(HS) and in patients with ulcerative colitis before (UC) 
and after surgery (IPAA). Values are mean ± SE. 
Citrate urinary excretion too was lower in IRRHC (t = 
4.22; p < 0.001) and in IPAA (t = 5.68; p < 0.001) 
groups when compared with the SF group. Urinary vol-
ume appeared significantly lower in IRRHC (t = 4.82; 
p < 0.001) and in IPAA (t = 9.93; p < 0.001) than in 
SF. On the contrary, GAGs excretion was similar 
(IRRHC) or even higher (IPAA: t = 2.02; p < 0.025) 
than in SF. Finally, urinary pH too was lower in 
IRRHC (t = 2.75; p < 0.001) and in IPAA (t = 4.45; 
p < 0.001) than in SF. The decreased urinary excretion 
of calcium, magnesium, uric acid and oxalate observed 
in patients with IBD after surgical treatment might be 
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explained by the lower urinary volume that, on the other 
hand, increases their concentration with the exception of 
the citrate. In fact, citrate urinary concentration was 
lower in patients with IBD after surgery than in SF. 
Discussion and Conclusions 
Renal stone formation has been shown to be a 
common complication in patients with IBD before and 
after surgery with a higher frequency than in the general 
population [10); in fact, we found a renal stone 
incidence of 8.3% at preoperative stage and of 11.9% 
after surgery. 
Several pathogenetic mechanisms promoting stone 
formation have been suggested [2, 5, 6, 21] and among 
them a pivotal role was attributed to the presence of 
enteric hyperoxaluria linked to a greater oxalate absorp-
tion at colon level. This mechanism was observed espe-
cially in patients with Crohn' s disease of the distal ileum 
without contemporary colon impairment, submitted to 
surgical treatment. Furthermore, urinary oxalate excre-
tion is usually normal, or even lower than in normal sub-
jects, in patients who have undergone total colectomy 
(Fig. 6). Our results show that several factors besides 
hyperoxaluria may be present in patients with IBD be-
fore and after surgical treatment even though their be-
haviour appears to be different in Crohn's disease and 
ulcerative colitis at pre- and postoperative stages. 
In patients with Crohn 's disease, the main risk 
factors seem to be a decreased citrate (Fig. 7) and mag-
nesium (Fig. 8) excretion together with a low urinary 
volume and pH (Table 3). Urinary volume reduction is 
probably one of the major risk factors inducing in these 
patients a higher concentration of oxalate, calcium and 
uric acid in comparison with HS (Table 4). Thus, uric 
acid and calcium oxalate saturation indices were in-
creased in almost all patients to the level of spontaneous 
precipitation (Fig. 4). Surgical treatment did not modify 
their degree of urinary saturation (Fig. 4). At this 
stage, patients with Crohn's disease displayed a further 










































Figures 7 and 8. Citrate (Figure 7) and magnesium 
(Figure 8) urinary excretion in healthy subjects (HS) and 
in patients with Crohn's disease before (CD) and after 
surgery (IRRHC). Values are mean ± SE. 
Figures 9 and 10. Citrate urinary excretion (Figure 9) 
and urinary pH (Figure 10) in healthy subjects (HS) and 
in patients with ulcerative colitis before (UC) and after 
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lowering of magnesium (Fig. 8) and citrate (Fig. 7) ex-
cretion although the urinary volume was increased. 
Moreover, hypocitraturia incidence increased from 38% 
before to 60.5 % after surgery. 
Also, patients with ulcerative colitis before sur-
gery presented some urinary abnormalities such as a re-
duced citrate excretion (Fig. 9) and a more acidic uri-
nary pH that might promote uric acid and/or calcium 
oxalate renal stone formation. Surgical treatment of 
proctocolectomy with ileal pouch-anal anastomosis 
seems to increase the risk of uric acid and/or calcium 
oxalate stone formation. In fact, after surgery a relevant 
decrease of urinary volume (Table 1), pH (Fig. 10) and 
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urinary excretion of small weight inhibitors (i.e., cit-
rate, magnesium) (Table 1) was observed. Urinary vol-
ume reduction (p < 0.02) (Table 1) again represents one 
of the major urinary risk factors inducing, in these pa-
tients, a relevant increase of oxalate and uric acid con-
centration and thus of their relative supersaturation 
indices (Fig. 1). 
The progressive lowering of pH values may also 
promote renal stone formation of uric acid or calcium 
oxalate through epitaxial growth mechanism. These al-
terations suggest that this type of surgical treatment also 
induces a continuous intestinal loss of water, sodium and 
alkali as already described [5, 21] in patients submitted 
to permanent ileostomy. The reduced urinary excretion 
of small weight inhibitors such as magnesium (p < 
0.005) (Table 1) and citrate (p < 0.01) (Fig. 9) is due 
to intestinal malabsorption of electrolytes (K, Mg) and 
bicarbonate [2]. In particular, after surgery a relevant 
increase was observed of hypocitraturia incidence that 
changes from 30% to 60.7%. The reduced excretion of 
small molecular weight inhibitors is a constant result in 
all patients with IBD, while we found a normal concen-
tration and excretion of high molecular weight inhibitor 
GAGs before and after surgery in all these patients. Our 
results showed a progressive increase of hypocitraturia 
incidence in both groups of patients after surgery; the 
hypocitraturia incidence of IRRHC and IP AA groups 
was significantly higher than that found in our idiopathic 
calcium stone formers (12.6%). Hypocitraturia has been 
recognized as a common biochemical abnormality in cal-
cium oxalate nephrolithiasis. Citrate is able to form 
soluble complexes with calcium and thus influences con-
siderably its availability for crystal formation [12, 19]. 
Moreover, citrate can absorb on the surfaces of calcium 
oxalate crystals and interfere with their growth and ag-
glomeration -[15, 19]. 
P,aJients with IBD present several urinary abnor-
malitiitS:,that may promote renal stone formation even 
though enteric hyperoxaluria is absent; moreover, there 
are some differences according to the type of IBD as 
well as to the time of patients' metabolic evaluation. In 
fact, patients with Crohn' s disease before surgery dis-
played a greater number of potential abnormalities which 
may promote the stone formation within the urinary tract 
than subjects affected by ulcerative colitis. Surgical 
treatment seems to modify the risk-factor pattern in-
creasing the probability of stone formation particularly 
in patients with ulcerative colitis. 
In conclusion, our results suggest that patients 
with IBD show a higher risk of renal stone formation in 
comparison with patients affected by idiopathic calcium 
lithiasis. Therefore, a careful metabolic follow-up 
seems to be very important to maintain the urinary level 
of lithogenetic factors near the normal range with 
therapeutic and dietary measures. 
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Discussion with Reviewers 
R.D. Rothstein and P .F. Malet: The authors state that 
all patients had normal renal function. It is unclear then 
what larger group these 66 patients with IBD were 
drawn from. One would assume that there were other 
IBD patients with impaired renal function. 
Authors: To evaluate the risk factors promoting renal 
379 
stone formation, a normal renal function is a prerequi-
site; in fact, an impairment of renal function introduces 
several modifications of the risk factors; so only the 
patients with normal renal function were sent to our 
laboratory for risk factors study. 
R.D. Rothstein and P.F. Malet: What medications the 
patients were on should be noted, as many medications 
could affect the metabolic status of the patients? 
Authors: As stated in the text, patients sent for the 
metabolic study did not receive any oral or parenteral 
supplementation or drugs at time of the urine analysis. 
R.D. Rothstein and P.F. Malet: Did any patients 
actually form stones? 
W .C. Thomas: Did any of the patients with inflam-
matory bowel disease have calculi? 
Authors: From our data, the incidence of renal stones 
at pre-operative stage as well as after surgery was 8.3 
and 11. 9 % . The number of patients with renal stones 
was slightly higher in those with Crohn' s disease, but 
the total number of patients is too low and the follow-up 
too short to obtain exact information about this point. 
The follow-up is now in progress confirming a higher 
incidence of stone formation in patients with Crohn' s 
disease without any difference between before and after 
surgery. 
R.D. Rothstein and P.F. Malet: There is a great 
overlap between UC and IPAA for CaOx; are these two 
populations truly different? 
Authors: As stated in the text, there were modifications 
before and after surgery of the concentration of both 
lithogenetic salts and inhibitors; supersaturation indices 
are modulated by the changes of these factors. In our 
patients, according to literature, the supersaturation in-
dices are very high and near to 1. These results justify 
the higher tendency to renal stone formation observed in 
these subjects and so the overlap between the two 
groups. 
H. Bohles: Please provide more information about the 
patients with respect to disease activity as defined by an 
activity index. 
Authors: We did not correlate the disease activity with 
the results of the risk factors as our aim was to evaluate 
the risk factors modifications in basal conditions and 
after surgery. 
W .C. Thomas: Please state the sex and age range of 
healthy subjects and those with idiopathic stone disease. 
Authors: In addition to data presented in the text, the 
results were not divided according to sex as there were 
too few patients in each group for a correct statistical 
evaluation. Moreover, we had previously studied the 
different excretion of lithogenetic salts and inhibitors 
according to sex in healthy subjects and calcium stone-
formers where we found some differences in healthy 
subjects between males and females. However, we 
R. Caudarella et al. 
found that these differences disappear in renal stone 
formers, even though there is not a general agreement in 
literature. In any case, if we consider, for example, the 
citrate excretion, a value lower than 250 mg/24h indi-
cates a pathological condition independent of sex. An-
other example could be the study of calcium excretion; 
in fact, we can speak of hypercalciuria when the calcium 
excretion is higher than 4 mg/kg/24h in males as well as 
in females. 
R.D. Rothstein and P.F. Malet: Can you compare, 
how the type of operation performed would physiologi-
cally influence the risk for nephrolithiasis? Are there 
any fundamental biological differences between Crohn's 
disease and ulcerative colitis that would differently 
affect the rate of stone formation? 
Authors: We can only give an appropriate answer to 
these questions when the follow up of our patients will 
be longer, although from our results patients with ulcer-
ative colitis after surgery show a greater number of po-
tential abnormalities, which may promote stone 
formation. 
R.D. Rothstein and P.F. Malet: How would fat malab-
sorption, that might be present, influence the risk of 
stone formation? 
Authors: The fat malabsorption might increase at colon 
level the oxalate absorption but in our patients 
steatorrhea was always absent. 
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